BioRestorative Therapies Statistics
Total Valuation
BRTX has a market cap or net worth of $11.17 million. The enterprise value is -$5.12 million.
| Market Cap | 11.17M |
| Enterprise Value | -5.12M |
Important Dates
The next estimated earnings date is Friday, August 9, 2024, after market close.
| Earnings Date | Aug 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BRTX has 6.77 million shares outstanding. The number of shares has increased by 79.46% in one year.
| Shares Outstanding | 6.77M |
| Shares Change (YoY) | +79.46% |
| Shares Change (QoQ) | +42.32% |
| Owned by Insiders (%) | 26.92% |
| Owned by Institutions (%) | 15.22% |
| Float | 4.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 74.72 |
| Forward PS | 42.12 |
| PB Ratio | 0.77 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.86, with a Debt / Equity ratio of 0.01.
| Current Ratio | 4.86 |
| Quick Ratio | 4.77 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -380.90 |
Financial Efficiency
Return on equity (ROE) is -55.90% and return on invested capital (ROIC) is -92.64%.
| Return on Equity (ROE) | -55.90% |
| Return on Assets (ROA) | -48.30% |
| Return on Capital (ROIC) | -92.64% |
| Revenue Per Employee | $13,591 |
| Profits Per Employee | -$632,431 |
| Employee Count | 11 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.25% in the last 52 weeks. The beta is 62.85, so BRTX's price volatility has been higher than the market average.
| Beta (5Y) | 62.85 |
| 52-Week Price Change | -46.25% |
| 50-Day Moving Average | 1.59 |
| 200-Day Moving Average | 1.64 |
| Relative Strength Index (RSI) | 44.16 |
| Average Volume (20 Days) | 115,246 |
Short Selling Information
The latest short interest is 268,750, so 3.97% of the outstanding shares have been sold short.
| Short Interest | 268,750 |
| Short Previous Month | 1.87M |
| Short % of Shares Out | 3.97% |
| Short % of Float | 5.43% |
| Short Ratio (days to cover) | 0.06 |
Income Statement
In the last 12 months, BRTX had revenue of $149,500 and -$6.96 million in losses. Loss per share was -$1.36.
| Revenue | 149,500 |
| Gross Profit | 149,500 |
| Operating Income | -13.55M |
| Pretax Income | -6.96M |
| Net Income | -6.96M |
| EBITDA | -6.67M |
| EBIT | -6.94M |
| Loss Per Share | -$1.36 |
Balance Sheet
The company has $16.42 million in cash and $123,536 in debt, giving a net cash position of $16.29 million or $2.41 per share.
| Cash & Cash Equivalents | 16.42M |
| Total Debt | 123,536 |
| Net Cash | 16.29M |
| Net Cash Per Share | $2.41 |
| Equity (Book Value) | 14.50M |
| Book Value Per Share | 2.14 |
| Working Capital | 13.32M |
Cash Flow
In the last 12 months, operating cash flow was -$6.40 million and capital expenditures -$111,021, giving a free cash flow of -$6.51 million.
| Operating Cash Flow | -6.40M |
| Capital Expenditures | -111,021 |
| Free Cash Flow | -6.51M |
| FCF Per Share | -$0.98 |
Margins
Gross margin is 100.00%, with operating and profit margins of -9,064.17% and -4,653.34%.
| Gross Margin | 100.00% |
| Operating Margin | -9,064.17% |
| Pretax Margin | -4,653.34% |
| Profit Margin | -4,653.34% |
| EBITDA Margin | -4,462.92% |
| EBIT Margin | -4,641.15% |
| FCF Margin | -4,354.70% |
Dividends & Yields
BRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -79.46% |
| Shareholder Yield | -79.46% |
| Earnings Yield | -62.28% |
| FCF Yield | -58.28% |
Analyst Forecast
The average price target for BRTX is $15.00, which is 809.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 809.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 266.76% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 27, 2021. It was a reverse split with a ratio of 1:4000.
| Last Split Date | Oct 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:4000 |
Scores
BRTX has an Altman Z-Score of -10.05 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.05 |
| Piotroski F-Score | 2 |